Expression of Concern: Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDupuytren's Contracture and Treatments · Medical and Biological Sciences · Cancer Diagnosis and Treatment
The PLOS One Editors issue this Expression of Concern due to issues identified after publication of this article [1] about compliance with data-related requirements specified in the study’s ethics approval documentation.
Additionally, the article was republished on January 16, 2025, to address an error. Please download this article again to view the correct version.
The article’s Data Availability statement is updated to: All relevant data are within the paper and its Supporting Information files.
Supporting information
S1 TableClinical and morphological features of MT patients.(XLSX)
The reference list from the paper itself. Each links out to its DOI / PubMed record.